GenMont Biotech Incorporation

NT$16.65As of Sun 8 Nov 2026, 12:00 UTC
TWSE:3164Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 0.73%
Div yield 4.80%
ROE 4.26%
Biotechnology
Beta (5Y) 0.05
PE TTM 20.79
TSR TTM (6.46%)
Mkt cap NT$1.432B
ROIC 1.75%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$22
29.42%
(16.77%)
Hold 8|0|12|6|8
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.19
0.19
0.18
0.19
25.83%
18.66%
12.21%
12.19%
RevenueNT$M
131.0
136.9
142.2
138.6
0.73%
6.84%
11.47%
10.65%
Peers (US$43.25M)
Cap (US$)
PE
46.65M
10.90x
Capital
TTM
5Y
10Y
Leveragex
4.231
0.040
0.031
EBIT/Intx
0.115
0.440
0.429
Own earn%
(131.51)
147.51
97.28
Sh yield%
10.07
33.47
34.38
Owners
Insiders/Inst%
13.34
88.33
Short interest%
2.12
SBC / revenue%
0.81
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
19–22
$1 testx
—
Incr. ROIC%
25